Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer

PIERCEALL, W., K. SPROTT, T. HEIKKINEN, P. HEIKKILA, L. ALAPARTHI, K. AITTOMAKI, M. AL-ADHAMI, V. VILLEGAS-BERGAZZI, J. MEYER, J. KUTOK, J. BARTKOVA, J. BÁRTEK, H. NEVANLINNA, D. WEAVER, C. BLOMQVIST